Article 17 of Regulation (EC) No 1223/2009 addresses the non-intended presence of small quantities of prohibited substances under specific conditions. Examine how this provision is interpreted in practice, the importance of technical unavoidability and good manufacturing practice, and the evidence needed to assess whether trace findings are compatible with product safety and compliance.